Medicine Description janumet 50/500mg
Janumet 50/500mg Tablets is a medication that combines two active ingredients: metformin and sitagliptin. Metformin primarily works by reducing hepatic glucose production and improving insulin sensitivity in peripheral tissues, particularly muscles. It enhances the uptake and utilization of glucose, contributing to decreased blood sugar levels. Sitagliptin, on the other hand, inhibits the enzyme dipeptidyl peptidase-4 (DPP-4), which inactivates incretin hormones. By inhibiting DPP-4, sitagliptin increases the levels of these hormones, leading to enhanced insulin secretion in response to meals and decreased glucagon secretion, which further aids in lowering blood glucose levels. The combined effect of these two mechanisms provides a comprehensive approach to managing blood sugar levels in adults with type 2 diabetes.
Indications and Uses of Janumet 50/500mg Tablets
- Management of type 2 diabetes in adults
- Used as an adjunct to diet and exercise
- Can be prescribed when monotherapy with metformin or sitagliptin is not sufficient
- May be part of a broader diabetes management plan including other medications
Side Effects of Janumet 50/500mg Tablets
- Nausea
- Diarrhea
- Abdominal discomfort
- Headache
- Upper respiratory tract infection
- Risk of pancreatitis
- Potential for lactic acidosis
Storage and Handling
Store Janumet 50/500mg Tablets at room temperature, away from moisture and heat. Ensure the medication is kept in its original packaging and out of reach of children.
Patient Advice and Precautions
Patients should be counseled about the importance of adhering to prescribed dietary and exercise regimens. Regular monitoring of blood glucose levels is essential. Inform healthcare providers about any changes in medical history or concurrent medications to avoid potential interactions. Report any symptoms of pancreatitis, such as severe abdominal pain, to a healthcare professional immediately.